Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NK-252 is a potential activator of Nrf2. It has great Nrf2-activating potential.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 33.00 | |
5 mg | In stock | $ 52.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 150.00 | |
50 mg | In stock | $ 256.00 | |
100 mg | In stock | $ 470.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 58.00 |
Description | NK-252 is a potential activator of Nrf2. It has great Nrf2-activating potential. |
In vitro | NK-252 shows this effect with higher potency than OPZ based on the fact that the EC2 value (concentration for a 2-fold induction above background), calculated with linear extrapolation from the values above and below the induction threshold, is 20.8 μM for OPZ and 1.36 μM for NK-252. NK-252 has potential as an Nrf2 activator in hepatic cells. The protective effects of OPZ and NK-252 are examined against H2O2-induced cytotoxicity using Huh-7 cells to evaluate their antioxidant properties. The cells treated with OPZ or NK-252 show increased resistance to H2O2-induced cytotoxicity compared with control cells. The luciferase activity in Huh-7.5 cells treated with Oltipraz (OPZ) or NK-252 displays activation of the NAD(P)H quinone oxidoreductase 1 (NQO1)-ARE in a dose-dependent manner. Prototypical Nrf2 activators that include OPZ have been reported to protect microglial cells from H2O2-induced cytotoxicity [1]. |
In vivo | Rats on a choline-deficient L-amino acid–defined (CDAA) diet that received OPZ or NK-252 exhibited decreased liver fibrosis scores compared to those on the same diet without these compounds. NK-252's impact on fibrosis was dose-dependent[1]. Compared to rats on a normal diet (naive), CDAA diet-fed rats showed a nearly 20-fold increase in liver fibrosis area, which was significantly reduced by OPZ or NK-252 treatments (5.80% for OPZ, 6.20% for NK-252_low, and 4.97% for NK-252_high). Although NK-252 did not show antitumor effects in P388/S- and P388/VCR-mice when used alone, its combination with Etoposide notably enhanced the lifespan of mice with P388/VCR cancer, more than Etoposide alone[2]. Similarly, oral administration of NK-252 with Etoposide significantly prolonged the lifespan of P388/S inoculated mice, showcasing an improved therapeutic outcome compared to using Etoposide by itself. |
Molecular Weight | 285.26 |
Formula | C13H11N5O3 |
CAS No. | 1414963-82-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 29 mg/mL (101.66 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NK-252 1414963-82-8 Immunology/Inflammation Others Nrf2 NK 252 inhibit NK252 Inhibitor Keap1-Nrf2 inhibitor